In vitro natamycin susceptibility of ocular isolates of Fusarium and Aspergillus species: Comparison of commercially formulated natamycin eye drops to pharmaceutical-grade powder

P. Lalitha; R. Vijaykumar; N. V. Prajna; A. W. Fothergill

doi:10.1128/JCM.00610-08

In vitro natamycin susceptibility of ocular isolates of Fusarium and Aspergillus species: Comparison of commercially formulated natamycin eye drops to pharmaceutical-grade powder

P. Lalitha, R. Vijaykumar, N. V. Prajna, A. W. Fothergill

Pathology

Research output: Contribution to journal › Article › peer-review

40 Scopus citations

Abstract

The Clinical and Laboratory Standards Institute susceptibility method prohibits the use of pharmacy preparations, but obtaining pure powders is difficult. The activity of natamycin against isolates of Aspergillus and Fusarium species isolated from keratitis was assessed by using both powder and pharmacy eye drop preparations. Eye drop preparations may be a viable option for testing natamycin activity.

Original language	English (US)
Pages (from-to)	3477-3478
Number of pages	2
Journal	Journal of clinical microbiology
Volume	46
Issue number	10
DOIs	https://doi.org/10.1128/JCM.00610-08
State	Published - Oct 2008

ASJC Scopus subject areas

Microbiology (medical)

Access to Document

10.1128/JCM.00610-08

Fingerprint Dive into the research topics of 'In vitro natamycin susceptibility of ocular isolates of Fusarium and Aspergillus species: Comparison of commercially formulated natamycin eye drops to pharmaceutical-grade powder'. Together they form a unique fingerprint.

Cite this

In vitro natamycin susceptibility of ocular isolates of Fusarium and Aspergillus species : Comparison of commercially formulated natamycin eye drops to pharmaceutical-grade powder. / Lalitha, P.; Vijaykumar, R.; Prajna, N. V.; Fothergill, A. W.

In: Journal of clinical microbiology, Vol. 46, No. 10, 10.2008, p. 3477-3478.

Research output: Contribution to journal › Article › peer-review

@article{b1b95c6181674e469af6f5d5adedf8b5,

title = "In vitro natamycin susceptibility of ocular isolates of Fusarium and Aspergillus species: Comparison of commercially formulated natamycin eye drops to pharmaceutical-grade powder",

abstract = "The Clinical and Laboratory Standards Institute susceptibility method prohibits the use of pharmacy preparations, but obtaining pure powders is difficult. The activity of natamycin against isolates of Aspergillus and Fusarium species isolated from keratitis was assessed by using both powder and pharmacy eye drop preparations. Eye drop preparations may be a viable option for testing natamycin activity.",

author = "P. Lalitha and R. Vijaykumar and Prajna, {N. V.} and Fothergill, {A. W.}",

year = "2008",

month = oct,

doi = "10.1128/JCM.00610-08",

language = "English (US)",

volume = "46",

pages = "3477--3478",

journal = "Journal of Clinical Microbiology",

issn = "0095-1137",

publisher = "American Society for Microbiology",

number = "10",

}

TY - JOUR

T1 - In vitro natamycin susceptibility of ocular isolates of Fusarium and Aspergillus species

T2 - Comparison of commercially formulated natamycin eye drops to pharmaceutical-grade powder

AU - Lalitha, P.

AU - Vijaykumar, R.

AU - Prajna, N. V.

AU - Fothergill, A. W.

PY - 2008/10

Y1 - 2008/10

N2 - The Clinical and Laboratory Standards Institute susceptibility method prohibits the use of pharmacy preparations, but obtaining pure powders is difficult. The activity of natamycin against isolates of Aspergillus and Fusarium species isolated from keratitis was assessed by using both powder and pharmacy eye drop preparations. Eye drop preparations may be a viable option for testing natamycin activity.

AB - The Clinical and Laboratory Standards Institute susceptibility method prohibits the use of pharmacy preparations, but obtaining pure powders is difficult. The activity of natamycin against isolates of Aspergillus and Fusarium species isolated from keratitis was assessed by using both powder and pharmacy eye drop preparations. Eye drop preparations may be a viable option for testing natamycin activity.

UR - http://www.scopus.com/inward/record.url?scp=53649090786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53649090786&partnerID=8YFLogxK

U2 - 10.1128/JCM.00610-08

DO - 10.1128/JCM.00610-08

M3 - Article

C2 - 18701666

AN - SCOPUS:53649090786

VL - 46

SP - 3477

EP - 3478

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 10

ER -